Logo image of SAM

BOSTON BEER COMPANY INC-A (SAM) Stock Fundamental Analysis

NYSE:SAM - New York Stock Exchange, Inc. - US1005571070 - Common Stock - Currency: USD

227.32  +2.17 (+0.96%)

After market: 227.32 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to SAM. SAM was compared to 31 industry peers in the Beverages industry. While SAM has a great health rating, there are worries on its profitability. SAM has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

SAM had positive earnings in the past year.
SAM had a positive operating cash flow in the past year.
In the past 5 years SAM has always been profitable.
Each year in the past 5 years SAM had a positive operating cash flow.
SAM Yearly Net Income VS EBIT VS OCF VS FCFSAM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M

1.2 Ratios

Looking at the Return On Assets, with a value of 5.81%, SAM is in line with its industry, outperforming 53.57% of the companies in the same industry.
The Return On Equity of SAM (7.92%) is worse than 71.43% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.85%, SAM is in line with its industry, outperforming 53.57% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for SAM is significantly below the industry average of 13.34%.
The 3 year average ROIC (6.09%) for SAM is below the current ROIC(9.85%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.81%
ROE 7.92%
ROIC 9.85%
ROA(3y)3.71%
ROA(5y)7.06%
ROE(3y)4.95%
ROE(5y)9.92%
ROIC(3y)6.09%
ROIC(5y)9.33%
SAM Yearly ROA, ROE, ROICSAM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20

1.3 Margins

The Profit Margin of SAM (4.01%) is worse than 71.43% of its industry peers.
In the last couple of years the Profit Margin of SAM has declined.
With a Operating Margin value of 7.68%, SAM is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
SAM's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 43.95%, SAM is not doing good in the industry: 60.71% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of SAM has declined.
Industry RankSector Rank
OM 7.68%
PM (TTM) 4.01%
GM 43.95%
OM growth 3Y-25.71%
OM growth 5Y-12.33%
PM growth 3Y-29.83%
PM growth 5Y-16.26%
GM growth 3Y-3.61%
GM growth 5Y-3.78%
SAM Yearly Profit, Operating, Gross MarginsSAM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30 40 50

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SAM is creating some value.
Compared to 1 year ago, SAM has less shares outstanding
The number of shares outstanding for SAM has been increased compared to 5 years ago.
The debt/assets ratio for SAM is higher compared to a year ago.
SAM Yearly Shares OutstandingSAM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
SAM Yearly Total Debt VS Total AssetsSAM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B

2.2 Solvency

SAM has an Altman-Z score of 6.62. This indicates that SAM is financially healthy and has little risk of bankruptcy at the moment.
SAM has a Altman-Z score of 6.62. This is amongst the best in the industry. SAM outperforms 82.14% of its industry peers.
There is no outstanding debt for SAM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 6.62
ROIC/WACC1.09
WACC9.06%
SAM Yearly LT Debt VS Equity VS FCFSAM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M 1B

2.3 Liquidity

SAM has a Current Ratio of 2.03. This indicates that SAM is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of SAM (2.03) is better than 60.71% of its industry peers.
A Quick Ratio of 1.42 indicates that SAM should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.42, SAM is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.03
Quick Ratio 1.42
SAM Yearly Current Assets VS Current LiabilitesSAM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

SAM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 37.43%, which is quite impressive.
SAM shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -3.99% yearly.
SAM shows a decrease in Revenue. In the last year, the revenue decreased by -2.81%.
Measured over the past years, SAM shows a quite strong growth in Revenue. The Revenue has been growing by 15.07% on average per year.
EPS 1Y (TTM)37.43%
EPS 3Y-26.52%
EPS 5Y-3.99%
EPS Q2Q%44.59%
Revenue 1Y (TTM)-2.81%
Revenue growth 3Y4.97%
Revenue growth 5Y15.07%
Sales Q2Q%0.64%

3.2 Future

SAM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.88% yearly.
The Revenue is expected to grow by 2.51% on average over the next years.
EPS Next Y45.31%
EPS Next 2Y38.23%
EPS Next 3Y31.92%
EPS Next 5Y25.88%
Revenue Next Year-1.32%
Revenue Next 2Y0.29%
Revenue Next 3Y1.24%
Revenue Next 5Y2.51%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SAM Yearly Revenue VS EstimatesSAM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B 2.5B
SAM Yearly EPS VS EstimatesSAM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10 20 30 40

5

4. Valuation

4.1 Price/Earnings Ratio

SAM is valuated rather expensively with a Price/Earnings ratio of 24.47.
SAM's Price/Earnings is on the same level as the industry average.
SAM's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 29.63.
With a Price/Forward Earnings ratio of 19.19, SAM is valued on the expensive side.
The rest of the industry has a similar Price/Forward Earnings ratio as SAM.
The average S&P500 Price/Forward Earnings ratio is at 22.68. SAM is around the same levels.
Industry RankSector Rank
PE 24.47
Fwd PE 19.19
SAM Price Earnings VS Forward Price EarningsSAM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

SAM's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. SAM is cheaper than 71.43% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SAM indicates a rather cheap valuation: SAM is cheaper than 85.71% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 15.2
EV/EBITDA 9.46
SAM Per share dataSAM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SAM's earnings are expected to grow with 31.92% in the coming years.
PEG (NY)0.54
PEG (5Y)N/A
EPS Next 2Y38.23%
EPS Next 3Y31.92%

0

5. Dividend

5.1 Amount

No dividends for SAM!.
Industry RankSector Rank
Dividend Yield N/A

BOSTON BEER COMPANY INC-A

NYSE:SAM (2/21/2025, 8:04:00 PM)

After market: 227.32 0 (0%)

227.32

+2.17 (+0.96%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)10-24 2024-10-24/amc
Earnings (Next)02-25 2025-02-25/amc
Inst Owners80.13%
Inst Owner Change4.98%
Ins Owners7.12%
Ins Owner Change-0.12%
Market Cap2.61B
Analysts52.73
Price Target301.17 (32.49%)
Short Float %7.01%
Short Ratio4.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.48%
Min EPS beat(2)-13.33%
Max EPS beat(2)6.37%
EPS beat(4)2
Avg EPS beat(4)2882.67%
Min EPS beat(4)-480.23%
Max EPS beat(4)12017.9%
EPS beat(8)3
Avg EPS beat(8)1398.56%
EPS beat(12)3
Avg EPS beat(12)918.21%
EPS beat(16)4
Avg EPS beat(16)683.88%
Revenue beat(2)0
Avg Revenue beat(2)-2.14%
Min Revenue beat(2)-4.01%
Max Revenue beat(2)-0.26%
Revenue beat(4)1
Avg Revenue beat(4)-1.99%
Min Revenue beat(4)-5.79%
Max Revenue beat(4)2.09%
Revenue beat(8)4
Avg Revenue beat(8)0.49%
Revenue beat(12)6
Avg Revenue beat(12)-0.04%
Revenue beat(16)9
Avg Revenue beat(16)0.54%
PT rev (1m)-4.13%
PT rev (3m)-2.11%
EPS NQ rev (1m)-3.92%
EPS NQ rev (3m)-3.92%
EPS NY rev (1m)-2.02%
EPS NY rev (3m)-2.7%
Revenue NQ rev (1m)-0.36%
Revenue NQ rev (3m)-0.36%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)-0.15%
Valuation
Industry RankSector Rank
PE 24.47
Fwd PE 19.19
P/S 1.3
P/FCF 15.2
P/OCF 10.89
P/B 2.57
P/tB 2.95
EV/EBITDA 9.46
EPS(TTM)9.29
EY4.09%
EPS(NY)11.85
Fwd EY5.21%
FCF(TTM)14.96
FCFY6.58%
OCF(TTM)20.88
OCFY9.19%
SpS174.59
BVpS88.34
TBVpS77.07
PEG (NY)0.54
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.81%
ROE 7.92%
ROCE 13.76%
ROIC 9.85%
ROICexc 12.77%
ROICexgc 15.02%
OM 7.68%
PM (TTM) 4.01%
GM 43.95%
FCFM 8.57%
ROA(3y)3.71%
ROA(5y)7.06%
ROE(3y)4.95%
ROE(5y)9.92%
ROIC(3y)6.09%
ROIC(5y)9.33%
ROICexc(3y)7.34%
ROICexc(5y)10.74%
ROICexgc(3y)9.03%
ROICexgc(5y)13.76%
ROCE(3y)8.5%
ROCE(5y)13.03%
ROICexcg growth 3Y-21.89%
ROICexcg growth 5Y-10.38%
ROICexc growth 3Y-20.67%
ROICexc growth 5Y-13.91%
OM growth 3Y-25.71%
OM growth 5Y-12.33%
PM growth 3Y-29.83%
PM growth 5Y-16.26%
GM growth 3Y-3.61%
GM growth 5Y-3.78%
F-Score8
Asset Turnover1.45
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 73.62%
Cap/Sales 3.4%
Interest Coverage 250
Cash Conversion 97.32%
Profit Quality 213.73%
Current Ratio 2.03
Quick Ratio 1.42
Altman-Z 6.62
F-Score8
WACC9.06%
ROIC/WACC1.09
Cap/Depr(3y)129.74%
Cap/Depr(5y)153.57%
Cap/Sales(3y)4.9%
Cap/Sales(5y)6.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.43%
EPS 3Y-26.52%
EPS 5Y-3.99%
EPS Q2Q%44.59%
EPS Next Y45.31%
EPS Next 2Y38.23%
EPS Next 3Y31.92%
EPS Next 5Y25.88%
Revenue 1Y (TTM)-2.81%
Revenue growth 3Y4.97%
Revenue growth 5Y15.07%
Sales Q2Q%0.64%
Revenue Next Year-1.32%
Revenue Next 2Y0.29%
Revenue Next 3Y1.24%
Revenue Next 5Y2.51%
EBIT growth 1Y17.47%
EBIT growth 3Y-22.02%
EBIT growth 5Y0.88%
EBIT Next Year88.39%
EBIT Next 3Y33.11%
EBIT Next 5Y27.33%
FCF growth 1Y29.09%
FCF growth 3Y21.03%
FCF growth 5Y13.26%
OCF growth 1Y4.1%
OCF growth 3Y1.52%
OCF growth 5Y10.17%